David Stieg

5PUBLICATIONS
15CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Immunogenetics (incl. genetic immunology)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 09, 2024
The Ashkenazi-Centric G334R Variant of TP53 is Severely Impaired for Transactivation but Retains Tumor Suppressor Function in a Mouse Model.

David C Stieg, Kaitlyn Casey, Bhanu Chandra Karisetty

|Jul 13, 2023
The African-centric P47S Variant of TP53 Confers Immune Dysregulation and Impaired Response to Immune Checkpoint Inhibition.

David C Stieg, Joshua L D Parris, Tyler Hong Loong Yang

|May 04, 2023
p53 Oligomerization Domain Mutants: A New Class of Mutants That Retain "License to Kill".

David Stieg, Kaitlyn Casey, Maureen E Murphy

|Jun 24, 2022
ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.

David C Stieg, Yifang Wang, Ling-Zhi Liu

|May 01, 2019
Cyclin C Regulated Oxidative Stress Responsive Transcriptome in Mus musculus Embryonic Fibroblasts.

David C Stieg, Kai-Ti Chang, Katrina F Cooper

Pageof 1